BIOMAT Database Logo BIOMAT Database Logo

Amino acids and peptides. XXXI. Preparation of analogs of the laminin-related peptide YIGSR and their inhibitory effect on experimental metastasis. 1998

M Maeda, and Y Izuno, and K Kawasaki, and Y Kaneda, and Y Mu, and Y Tsutsumi, and S Nakagawa, and T Mayumi
Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Japan.

Analogs of a partial sequence peptide of laminin, i.e., Tyr-Ile-Gly-Ser-Arg (YIGSR) analogs and Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg (CDPGYIGSR) analogs, were prepared by the solid-phase method and their inhibitory effects on experimental metastasis of B16-BL6 melanoma cells were examined. YIGSR analogs in which Ile was replaced by other hydrophobic amino acids (Met, Leu, Phe) were inhibitory. Cys-containing analogs of YIGSR were also prepared, but were less active than the parent peptide, YIGSR. Among them, CYIGSR was easily oxidized to form a disulfide bond. A Cys-containing YIGSR analog cyclized through a disulfide bond, cyclo(CYIGSRC)G, was prepared. The disulfide bond formation was performed on the resin by the silyl chloride-sulfoxide method and by the iodine oxidation method. The yield of the silyl chloride-sulfoxide method was much better than that of the iodine oxidation method.

UI MeSH Term Description Entries
D007797 Laminin Large, noncollagenous glycoprotein with antigenic properties. It is localized in the basement membrane lamina lucida and functions to bind epithelial cells to the basement membrane. Evidence suggests that the protein plays a role in tumor invasion. Merosin,Glycoprotein GP-2,Laminin M,Laminin M Chain,Chain, Laminin M,Glycoprotein GP 2,M Chain, Laminin
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008546 Melanoma, Experimental Experimentally induced tumor that produces MELANIN in animals to provide a model for studying human MELANOMA. B16 Melanoma,Melanoma, B16,Melanoma, Cloudman S91,Melanoma, Harding-Passey,Experimental Melanoma,Experimental Melanomas,Harding Passey Melanoma,Melanomas, Experimental,B16 Melanomas,Cloudman S91 Melanoma,Harding-Passey Melanoma,Melanoma, Harding Passey,Melanomas, B16,S91 Melanoma, Cloudman
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

M Maeda, and Y Izuno, and K Kawasaki, and Y Kaneda, and Y Mu, and Y Tsutsumi, and S Nakagawa, and T Mayumi
Amino acids and peptides. XXI. Laminin-related peptide analogs including poly(ethylene glycol) hybrids and their inhibitory effect on experimental metastasis.
April 1994, Chemical & pharmaceutical bulletin,
M Maeda, and Y Izuno, and K Kawasaki, and Y Kaneda, and Y Mu, and Y Tsutsumi, and S Nakagawa, and T Mayumi
Amino acids and peptides. XIV. Laminin related peptides and their inhibitory effect on experimental metastasis formation.
February 1991, Biochemical and biophysical research communications,
M Maeda, and Y Izuno, and K Kawasaki, and Y Kaneda, and Y Mu, and Y Tsutsumi, and S Nakagawa, and T Mayumi
Amino acids and peptides. XXV. Preparation of fibronectin-related peptide poly(ethylene glycol) hybrids and their inhibitory effect on experimental metastasis.
December 1995, Chemical & pharmaceutical bulletin,
M Maeda, and Y Izuno, and K Kawasaki, and Y Kaneda, and Y Mu, and Y Tsutsumi, and S Nakagawa, and T Mayumi
Effect of Matrigel and laminin peptide YIGSR on tumor growth and metastasis.
August 1993, Seminars in cancer biology,
M Maeda, and Y Izuno, and K Kawasaki, and Y Kaneda, and Y Mu, and Y Tsutsumi, and S Nakagawa, and T Mayumi
Synthetic peptides related to laminin pentapeptide (YIGSR) fragment.
July 1996, Indian journal of experimental biology,
M Maeda, and Y Izuno, and K Kawasaki, and Y Kaneda, and Y Mu, and Y Tsutsumi, and S Nakagawa, and T Mayumi
YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation.
November 1987, Science (New York, N.Y.),
M Maeda, and Y Izuno, and K Kawasaki, and Y Kaneda, and Y Mu, and Y Tsutsumi, and S Nakagawa, and T Mayumi
Amino acids and peptides. XXVIII. Preparation of poly(ethylene glycol) hybrids of Gln-Val-Val-Ala-Gly analogs and their inhibitory effect on papain.
June 1996, Biological & pharmaceutical bulletin,
M Maeda, and Y Izuno, and K Kawasaki, and Y Kaneda, and Y Mu, and Y Tsutsumi, and S Nakagawa, and T Mayumi
Preparation of [Arg-Gly-Asp]-[amino-poly(ethylene glycol)] hybrids and their inhibitory effect on experimental metastasis.
December 1991, Chemical & pharmaceutical bulletin,
M Maeda, and Y Izuno, and K Kawasaki, and Y Kaneda, and Y Mu, and Y Tsutsumi, and S Nakagawa, and T Mayumi
YIGSR, a synthetic laminin peptide, inhibits the enhancement by cyclophosphamide of experimental lung metastasis of human fibrosarcoma cells.
May 1992, Clinical & experimental metastasis,
M Maeda, and Y Izuno, and K Kawasaki, and Y Kaneda, and Y Mu, and Y Tsutsumi, and S Nakagawa, and T Mayumi
Synthesis and activity of partial retro-inverso analogs of the antimetastatic laminin-derived peptide, YIGSR-NH2.
March 1997, The journal of peptide research : official journal of the American Peptide Society,
Copied contents to your clipboard!